Breaking News Instant updates and real-time market news.

SMWB

Similarweb

$21.75 /

+0.15 (+0.69%)

06:48
06/07/21
06/07
06:48
06/07/21
06:48

Similarweb initiated with a Buy at Citi

Citi analyst Tyler Radke initiated coverage of Similarweb with a Buy rating and $32 price target. SimilarWeb's "differentiated" alternative data platform is poised to benefit as organizations spend more on broader digitization and data-driven initiatives, Radke tells investors in a research note. The analyst believes the company's growth is likely to reaccelerate in the near-term driven by easing comps post Covid and increased go-to-market investments.

  • 12

    May

SMWB Similarweb
$21.75 /

+0.15 (+0.69%)

06/07/21 JMP Securities
Similarweb initiated with an Outperform at JMP Securities
06/07/21 Barclays
Similarweb initiated with an Equal Weight at Barclays
06/07/21 Jefferies
Similarweb initiated with a Hold at Jefferies

TODAY'S FREE FLY STORIES

Recommendations
Patterson earnings pullback a buying opportunity, says Piper Sandler » 08:42
06/23/21
06/23
08:42
06/23/21
08:42
PDCO

Patterson Companies

$35.16 /

-0.15 (-0.42%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PDCO Patterson Companies
$35.16 /

-0.15 (-0.42%)

PDCO Patterson Companies
$35.16 /

-0.15 (-0.42%)

06/17/21
Fly Intel: Top five analyst upgrades
06/17/21 Piper Sandler
Patterson Companies upgraded to Overweight from Neutral at Piper Sandler
03/03/21 Piper Sandler
Piper stays Neutral Patterson despite execution due to 'lingering uncertainty'
12/30/20 Piper Sandler
Patterson contract loss unexpected but manageable, says Piper Sandler
PDCO Patterson Companies
$35.16 /

-0.15 (-0.42%)

PDCO Patterson Companies
$35.16 /

-0.15 (-0.42%)

Hot Stocks
Gilead joint venture receives China NMPA approval for axicabtagene ciloleucel » 08:42
06/23/21
06/23
08:42
06/23/21
08:42
GILD

Gilead

$67.07 /

-0.25 (-0.37%)

Kite, a Gilead company,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$67.07 /

-0.25 (-0.37%)

GILD Gilead
$67.07 /

-0.25 (-0.37%)

06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
GILD Gilead
$67.07 /

-0.25 (-0.37%)

GILD Gilead
$67.07 /

-0.25 (-0.37%)

GILD Gilead
$67.07 /

-0.25 (-0.37%)

GILD Gilead
$67.07 /

-0.25 (-0.37%)

Hot Stocks
Climb Channel partners with StorONE to distribute software defined storage » 08:42
06/23/21
06/23
08:42
06/23/21
08:42
WSTG

Wayside Technology

$24.70 /

-0.775 (-3.04%)

Climb Channel Solutions,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WSTG Wayside Technology
$24.70 /

-0.775 (-3.04%)

Hot Stocks
Amdocs announces new solutions for CES21 suite » 08:42
06/23/21
06/23
08:42
06/23/21
08:42
DOX

Amdocs

$79.02 /

-0.2399 (-0.30%)

Amdocs announced its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

04/01/21 JPMorgan
Amdocs should 'bounce-back' after short report, says JPMorgan
03/31/21 JPMorgan
Prior Amdocs short report turned out a 'great buying opportunity,' says JPMorgan
02/11/21 Oppenheimer
Amdocs assumed with an Outperform at Oppenheimer
02/03/21 Citi
Amdocs price target raised to $87 from $82 at Citi
DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

Hot Stocks
Jaguar Health set to join the Russell Microcap Index » 08:42
06/23/21
06/23
08:42
06/23/21
08:42
JAGX

Jaguar Health

$1.68 /

-0.01 (-0.59%)

Jaguar Health announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JAGX Jaguar Health
$1.68 /

-0.01 (-0.59%)

JAGX Jaguar Health
$1.68 /

-0.01 (-0.59%)

02/24/21 Ladenburg
Jaguar Health transferred with Buy, $3.75 target at Ladenburg
JAGX Jaguar Health
$1.68 /

-0.01 (-0.59%)

JAGX Jaguar Health
$1.68 /

-0.01 (-0.59%)

Hot Stocks
Herborium Group reports Q1 sales up 19.7% » 08:41
06/23/21
06/23
08:41
06/23/21
08:41
HBRM

Herborium Group

/

+

Herborium Group announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HBRM Herborium Group
/

+

Syndicate
BioXcel Therapeutics 3.155M share Spot Secondary priced at $31.70 » 08:41
06/23/21
06/23
08:41
06/23/21
08:41
BTAI

BioXcel Therapeutics

$36.88 /

-1.38 (-3.61%)

The deal priced at bottom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTAI BioXcel Therapeutics
$36.88 /

-1.38 (-3.61%)

BTAI BioXcel Therapeutics
$36.88 /

-1.38 (-3.61%)

07:13 Today Truist
BioXcel Therapeutics price target lowered to $125 from $128 at Truist
06/01/21 H.C. Wainwright
BioXcel Therapeutics price target raised to $176 from $170 at H.C. Wainwright
05/11/21 H.C. Wainwright
BioXcel Therapeutics price target lowered to $170 from $175 at H.C. Wainwright
04/09/21 Berenberg
BioXcel Therapeutics initiated with a Buy at Berenberg
BTAI BioXcel Therapeutics
$36.88 /

-1.38 (-3.61%)

  • 23
    Jun
  • 29
    Jul
BTAI BioXcel Therapeutics
$36.88 /

-1.38 (-3.61%)

Hot Stocks
AMMO awarded U.S. Department of Defense contract for developing BM-MPR » 08:39
06/23/21
06/23
08:39
06/23/21
08:39
POWW

AMMO

$8.50 /

+0.75 (+9.68%)

AMMO announce it has been…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
POWW AMMO
$8.50 /

+0.75 (+9.68%)

POWW AMMO
$8.50 /

+0.75 (+9.68%)

04/22/21
Fly Intel: Top five analyst initiations
04/22/21 Lake Street
AMMO initiated with a Buy at Lake Street
04/08/21 Roth Capital
AMMO initiated with a Buy at Roth Capital
POWW AMMO
$8.50 /

+0.75 (+9.68%)

  • 12
    Mar
  • 01
    Dec
POWW AMMO
$8.50 /

+0.75 (+9.68%)

POWW AMMO
$8.50 /

+0.75 (+9.68%)

Hot Stocks
Liminal BioSciences signs share purchase agreement for plasma business sale » 08:39
06/23/21
06/23
08:39
06/23/21
08:39
LMNL

Liminal BioSciences

$4.07 /

+0.03 (+0.74%)

Liminal BioSciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LMNL Liminal BioSciences
$4.07 /

+0.03 (+0.74%)

LMNL Liminal BioSciences
$4.07 /

+0.03 (+0.74%)

06/02/21
Fly Intel: Top five analyst downgrades
06/01/21 Piper Sandler
Liminal BioSciences downgraded to Neutral from Overweight at Piper Sandler
05/18/21 Piper Sandler
Piper says Liminal partnering plasma franchise to Kedrion 'a great catalyst'
03/25/21 Piper Sandler
Liminal BioSciences positioned for transformational year, says Piper Sandler
LMNL Liminal BioSciences
$4.07 /

+0.03 (+0.74%)

Recommendations
Plug Power price target raised to $51 from $50 at B. Riley » 08:39
06/23/21
06/23
08:39
06/23/21
08:39
PLUG

Plug Power

$34.00 /

+4.125 (+13.81%)

B. Riley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLUG Plug Power
$34.00 /

+4.125 (+13.81%)

PLUG Plug Power
$34.00 /

+4.125 (+13.81%)

07:08 Today Canaccord
Canaccord downgrades Plug Power on valuation, higher costs
06:18 Today Barclays
Plug Power price target raised to $27 from $24 at Barclays
05:35 Today Canaccord
Plug Power downgraded to Hold from Buy at Canaccord
06/22/21 Craig-Hallum
Plug Power Q1 filing, reiterated guidance removes overhang, says Craig-Hallum
PLUG Plug Power
$34.00 /

+4.125 (+13.81%)

  • 27
    Jan
  • 17
    Nov
  • 12
    Aug
PLUG Plug Power
$34.00 /

+4.125 (+13.81%)

PLUG Plug Power
$34.00 /

+4.125 (+13.81%)

PLUG Plug Power
$34.00 /

+4.125 (+13.81%)

Hot Stocks
AstroNova says China's CAAC awards company repair station certification » 08:39
06/23/21
06/23
08:39
06/23/21
08:39
ALOT

AstroNova

$13.94 /

+0.18 (+1.31%)

AstroNova announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
BofA upgrades UGI Corporation to Buy on earnings growth from renewables » 08:38
06/23/21
06/23
08:38
06/23/21
08:38
UGI

UGI Corporation

$45.50 /

-0.79 (-1.71%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UGI UGI Corporation
$45.50 /

-0.79 (-1.71%)

UGI UGI Corporation
$45.50 /

-0.79 (-1.71%)

08:31 Today BofA
UGI Corporation upgraded to Buy from Neutral at BofA
06/22/21 Barclays
UGI Corporation price target raised to $43 from $39 at Barclays
12/23/20 BofA
UGI Corporation reinstated with a Neutral at BofA
07/16/20 Barclays
UGI Corporation upgraded to Equal Weight from Underweight at Barclays
UGI UGI Corporation
$45.50 /

-0.79 (-1.71%)

Hot Stocks
Amdocs announces release of Amdocs CES21 » 08:38
06/23/21
06/23
08:38
06/23/21
08:38
DOX

Amdocs

$79.02 /

-0.2399 (-0.30%)

Amdocs announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

04/01/21 JPMorgan
Amdocs should 'bounce-back' after short report, says JPMorgan
03/31/21 JPMorgan
Prior Amdocs short report turned out a 'great buying opportunity,' says JPMorgan
02/11/21 Oppenheimer
Amdocs assumed with an Outperform at Oppenheimer
02/03/21 Citi
Amdocs price target raised to $87 from $82 at Citi
DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

Hot Stocks
Amdocs launches Experience360 platform » 08:38
06/23/21
06/23
08:38
06/23/21
08:38
DOX

Amdocs

$79.02 /

-0.2399 (-0.30%)

Amdocs announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

04/01/21 JPMorgan
Amdocs should 'bounce-back' after short report, says JPMorgan
03/31/21 JPMorgan
Prior Amdocs short report turned out a 'great buying opportunity,' says JPMorgan
02/11/21 Oppenheimer
Amdocs assumed with an Outperform at Oppenheimer
02/03/21 Citi
Amdocs price target raised to $87 from $82 at Citi
DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

DOX Amdocs
$79.02 /

-0.2399 (-0.30%)

Hot Stocks
Chemomab Therapeutics, AGC Biologics expand partnership to manufacture CM-101 » 08:38
06/23/21
06/23
08:38
06/23/21
08:38
CMMB

Chemomab Therapeutics

$22.55 /

+0.16 (+0.71%)

Chemomab Therapeutics and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMMB Chemomab Therapeutics
$22.55 /

+0.16 (+0.71%)

CMMB Chemomab Therapeutics
$22.55 /

+0.16 (+0.71%)

05/26/21 Cantor Fitzgerald
Chemomab Therapeutics initiated with an Overweight at Cantor Fitzgerald
05/07/21 Oppenheimer
Chemomab Therapeutics initiated with an Outperform at Oppenheimer
CMMB Chemomab Therapeutics
$22.55 /

+0.16 (+0.71%)

Recommendations
DigitalBridge price target raised to $12 from $11 at B. Riley » 08:36
06/23/21
06/23
08:36
06/23/21
08:36
DBRG

DigitalBridge

$8.42 /

-0.07 (-0.82%)

B. Riley analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DBRG DigitalBridge
$8.42 /

-0.07 (-0.82%)

DBRG DigitalBridge
$8.42 /

-0.07 (-0.82%)

07:39 Today Truist
DigitalBridge price target raised to $11 from $8 at Truist
06/21/21 Wells Fargo
Colony Capital initiated with an Overweight at Wells Fargo
DBRG DigitalBridge
$8.42 /

-0.07 (-0.82%)

DBRG DigitalBridge
$8.42 /

-0.07 (-0.82%)

Hot Stocks
Quanta's Medolife Rx announces FDA acceptance of COVID-19 study » 08:36
06/23/21
06/23
08:36
06/23/21
08:36
QNTA

Quanta

/

+

Medolife Rx announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QNTA Quanta
/

+

Hot Stocks
Entera Bio announce phase 2 BMD data for EB613 » 08:36
06/23/21
06/23
08:36
06/23/21
08:36
ENTX

Entera Bio

$4.50 /

-0.07 (-1.53%)

Entera Bio announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENTX Entera Bio
$4.50 /

-0.07 (-1.53%)

ENTX Entera Bio
$4.50 /

-0.07 (-1.53%)

06/16/21 B. Riley
Entera Bio initiated with a Buy, $9 target at B. Riley
06/16/21 B. Riley
Entera Bio initiated with a Buy at B. Riley
03/22/21 Aegis
Entera Bio initiated with a Buy at Aegis
03/11/21 Maxim
Entera Bio price target raised to $10 from $5 at Maxim
ENTX Entera Bio
$4.50 /

-0.07 (-1.53%)

ENTX Entera Bio
$4.50 /

-0.07 (-1.53%)

Hot Stocks
Genprex begins Acclaim-1 trial for REQORSA in combo for NSCLC treatment » 08:35
06/23/21
06/23
08:35
06/23/21
08:35
GNPX

Genprex

$3.30 /

-0.06 (-1.79%)

Genprex announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GNPX Genprex
$3.30 /

-0.06 (-1.79%)

GNPX Genprex
$3.30 /

-0.06 (-1.79%)

01/26/21 National Securities
Genprex initiated with a Buy at National Securities
Hot Stocks
Luokung Technology subsidiary's HD map standards approved in China » 08:35
06/23/21
06/23
08:35
06/23/21
08:35
LKCO

Luokung Technology

$2.53 /

-0.005 (-0.20%)

Luokung Technology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LKCO Luokung Technology
$2.53 /

-0.005 (-0.20%)

LKCO Luokung Technology
$2.53 /

-0.005 (-0.20%)

Recommendations
Cassava Sciences price target raised to $111 from $78 at B. Riley » 08:35
06/23/21
06/23
08:35
06/23/21
08:35
SAVA

Cassava Sciences

$77.57 /

-12.08 (-13.47%)

B. Riley analyst Mayank…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAVA Cassava Sciences
$77.57 /

-12.08 (-13.47%)

SAVA Cassava Sciences
$77.57 /

-12.08 (-13.47%)

04/27/21 B. Riley
B. Riley starts Cassava Sciences at Buy on Alzheimer's focus
04/27/21 B. Riley
Cassava Sciences initiated with a Buy at B. Riley
03/17/21 JonesTrading
JonesTrading starts Alzheimer's 'pure play' Cassava Sciences at Buy
03/17/21 JonesTrading
Cassava Sciences initiated with a Buy at JonesTrading
SAVA Cassava Sciences
$77.57 /

-12.08 (-13.47%)

  • 13
    Nov
SAVA Cassava Sciences
$77.57 /

-12.08 (-13.47%)

SAVA Cassava Sciences
$77.57 /

-12.08 (-13.47%)

Hot Stocks
Iron Mountain sells portfolio of five facilities to ICG for $178M » 08:34
06/23/21
06/23
08:34
06/23/21
08:34
IRM

Iron Mountain

$43.75 /

-1.64 (-3.61%)

Iron Mountain announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IRM Iron Mountain
$43.75 /

-1.64 (-3.61%)

IRM Iron Mountain
$43.75 /

-1.64 (-3.61%)

02/25/21 Wells Fargo
Iron Mountain price target raised to $38 from $32 at Wells Fargo
IRM Iron Mountain
$43.75 /

-1.64 (-3.61%)

IRM Iron Mountain
$43.75 /

-1.64 (-3.61%)

Hot Stocks
XBiotech announces first patient enrolled in clinical trial evaluating XB2001 » 08:33
06/23/21
06/23
08:33
06/23/21
08:33
XBIT

XBiotech

$16.21 /

+0.57 (+3.64%)

XBiotech has enrolled the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XBIT XBiotech
$16.21 /

+0.57 (+3.64%)

Upgrade
First Horizon upgraded to Outperform from Market Perform at Hovde Group » 08:33
06/23/21
06/23
08:33
06/23/21
08:33
FHN

First Horizon

$17.20 /

+0.015 (+0.09%)

Hovde Group analyst Brett…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FHN First Horizon
$17.20 /

+0.015 (+0.09%)

FHN First Horizon
$17.20 /

+0.015 (+0.09%)

10/08/20 Jefferies
First Horizon upgraded to Buy from Hold at Jefferies
09/22/20 Raymond James
First Horizon upgraded to Strong Buy from Outperform at Raymond James
08/20/20 Goldman Sachs
First Horizon reinstated with a Buy at Goldman Sachs
08/17/20 Morgan Stanley
First Horizon resumed with an Equal Weight at Morgan Stanley
FHN First Horizon
$17.20 /

+0.015 (+0.09%)

FHN First Horizon
$17.20 /

+0.015 (+0.09%)

Hot Stocks
Jounce Therapeutics announces anticipated milestones » 08:33
06/23/21
06/23
08:33
06/23/21
08:33
JNCE

Jounce Therapeutics

$7.42 /

-0.33 (-4.26%)

JTX-8064: Establish…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNCE Jounce Therapeutics
$7.42 /

-0.33 (-4.26%)

JNCE Jounce Therapeutics
$7.42 /

-0.33 (-4.26%)

06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
03/14/21 Piper Sandler
Jounce Therapeutics initiated with an Overweight at Piper Sandler
JNCE Jounce Therapeutics
$7.42 /

-0.33 (-4.26%)

  • 10
    Mar
JNCE Jounce Therapeutics
$7.42 /

-0.33 (-4.26%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.